News for Suven Life Sciences Limited (SUVEN.BO)

A smallcap rally is exciting investors, with the BSE Smallcap Index rising nearly 10% in a month and many stocks delivering over 30% returns. However, earnings growth lags behind, with smallcaps showing lower profit growth compared to largecaps. Experts advise caution, suggesting a focus on fundamentals and a potential shift towards largecaps due to stretched valuations in the smallcap segment.

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True North.

Suven Pharmaceuticals Ltd. named Vivek Sharma as the new executive Chairman of the firm, taking over the position from Vaidheesh Annaswamy according to a press release from the firm on BSE.

Suven Life Sciences' Ropanicant shows promise for MDD treatment, with positive Phase 2a results and plans for Phase 2b study.

The study aimed to evaluate the safety and tolerability of Ropanicant in patients with Major Depressive Disorder: suven lifesciences share price

Suven Life Sciences reports ₹28 crore net loss, stock down 5% on BSE; ongoing clinical trials for Alzheimer's and depression.

Suven Life Q1 FY25 Results: Suven Life Sciences reports ₹28 crore net loss, stock down 5% on BSE; ongoing clinical trials for Alzheimer's and depression.

Her biggest chunk of wealth is derived from the sale of a stake in a pharma company.

The quarterly earnings season commenced in the second week of April and remains ongoing, with more than 260 companies slated to announce their fourth-quarter earnings throughout this week.

The FY24 has been a turnaround year for smallcap stocks, witnessing a significant rally with many stocks turning multibaggers. However, concerns over valuations raised by Sebi might moderate returns in FY25. While equity bulls partied hard in most of FY24, the Securities and Exchange Board India (Sebi) turned a party spoiler towards the end.

The global Carglumic Acid market is anticipated to grow from USD 138.27 million to USD 281.81 million in 10 years. The market is likely to experience...

Foreign institutional investors (FIIs) sold equities worth of Rs 3,901.27 crore, while Domestic institutional investors (DIIs) bought equities worth Rs 6,858.47 crore.

In this week, Indian rupee closed higher against the US dollar. The domestic currency gained 24 paise to end at 82.92 in the week ended January 12 against January 5 closing of 83.16.

Suven Life Sciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 30.6 million compared...

Among sectors, the BSE realty index added 10 percent, the telecom index 5.3 percent and the oil & gas index gained 3.6 percent but the auto index closed nearly a percent lower

Indian rupee ended marginally lower against the US dollar at 83.29 in the week ended November 3 against October 27 closing of 83.24.

Based on the OI percentage, 81 stocks were on the short-covering list. These include Indraprastha Gas, Britannia Industries, Dr Lal PathLabs, Mahanagar Gas, and Maruti Suzuki India.

Continuous foreign fund outflows and weak trend in Asian and European markets also played spoilsport for the domestic markets

Suven Life Sciences announces two poster presentations including patient baseline characteristics and demographics from the phase-2 Proof of Concept study on samelisant at... | June 3, 2023